Get the Latest Information on Medical Marijuana with On-line Education

OSUWexnerbloglogo2014 Get the Latest Information on Medical Marijuana with On-line Education. One of the most recent states to legalize medical marijuana is Ohio where a new medical marijuana law went into effect earlier this month. But it is not without controversy, however. And it is really difficult to find objective, scientific data on the medicinal effects of marijuana. On this CME webcast, we’ve brought in two of the Ohio State University’s top experts on marijuana to give us an unbiased review of medical marijuana and we’re going to frame the discussion in the context of Ohio’s new medical marijuana law. To review the pharmacology of marijuana, palliative medicine clinical pharmacist, and to tell us more about the medical uses of marijuana is Professor of Internal Medicine and the long-standing chairman of the OSU Pharmacy and Therapeutics committee, Dr. Harrison Weed.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the currently accepted appropriate uses of medical marijuana; and UNDERSTAND the potential
adverse consequences of medical marijuana.

You’ll also learn about the following:

  • Current pharmacologic uses of cannabinoids
  • Medicinal properties of marijuana
  • Hemp versus marijuana
  • The Ohio Automated Rx Reporting System (OARRS)
  • Hospital approaches to inpatient use of medical marijuana
  • Purity testing and labeling

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Sleep-Heart Interactions on CME Webcast

OSUWexnerbloglogo2014 Learn About Sleep-Heart Interactions on CME Webcast. The interactions between sleep disorders and heart disease are complex and today on MedNet, we’re going to unravel some of that complexity. Joining us in the studio is pulmonologist, sleep specialist, and Professor of Internal Medicine, Dr. Rami Khayat.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the mechanism of vascular disease in OSA; and DISCUSS the results of recent trials in the treatment of SDB.

You’ll also learn about the following:

  • The relationship between sleep disorders and cardiovascular disorders
  • Epidemiology of obstructive sleep apnea
  • Office-based screening for sleep apnea
  • Screening sleep studies in patients with cardiovascular disease
  • New methods for sleep apnea testing
  • Clues from the 24-hour blood pressure study
  • CPAP versus BiPAP
  • New devices for home non-invasive ventilation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Telemedicine on CME Webcast

OSUWexnerbloglogo2014 Learn About Telemedicine on CME Webcast. On this CME webcast, we’re going to show you some of the innovations in telemedicine and how it is being used in two specialties at The Ohio State University. First, to tell us about telepsychiatry is Assistant Professor of Psychiatry, Dr. Natalie Lester. And then to tell us about teledermatology is Assistant Professor of Internal Medicine, Dr. Benjamin Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the use of live-interactive telemedicine; RECOGNIZE advantages and pitfalls in this technology, using telepsychiatry as an example; UNDERSTAND the use of store-and-forward telemedicine; RECOGNIZE advantages and pitfalls in this technology, using dermatology as an example.

You’ll also learn about the following:

  • Efficacy of telepsychiatry
  • Obstacles in adapting telemedicine for dermatology
  • Using telepsychiatry with non-English speaking patients
  • Telepsychiatry in child and geriatric psychiatry
  • 2-D versus 3-D imaging
  • Other current applications of telemedicine at the Ohio State University

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Education Discusses Lymphoma

OSUWexnerbloglogo2014 On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.

You’ll also learn about the following:

  • What causes lymphoma
  • The spectrum of lymphomas
  • Stem cell transplant in aggressive lymphomas
  • Whether there a role for “maintenance rituximab”
  • Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
  • Lymphoma mimics
  • Deciding when to biopsy an enlarged lymph node

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.